|4Jun 28, 4:30 PM ET

Kung Winston 4

4 · Janux Therapeutics, Inc. · Filed Jun 28, 2024

Insider Transaction Report

Form 4
Period: 2024-06-26
Kung Winston
Director
Transactions
  • Award

    Stock Option (right to buy)

    2024-06-26+8,3508,350 total
    Exercise: $39.80Exp: 2034-06-25Common Stock (8,350 underlying)
  • Award

    Common Stock

    2024-06-26+2,5002,500 total
Footnotes (2)
  • [F1]Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 26, 2025 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date.
  • [F2]The shares subject to the option will vest in equal monthly installments over the 12 months following June 26, 2024, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on each such date.

Documents

1 file
  • 4
    form4-06282024_040641.xmlPrimary